Modalis Therapeutics Corporation
Notice of Large-Scale Exercise of the 19th Warrant with Exercise Price Adjustment Clauses Issued through Third-Party Allotment
4,500,000 shares issued since the beginning of the month, 45,000 warrants exercised by September 10. Unexercised rights count to 93,700 (9,370,000 shares). Total number of issued warrants is 240,000, and the number of issued shares as of the previous fiscal year-end was 106,464,098 shares.
Key Figures
- Issued shares: 4,500,000 shares
- Number of warrants exercised: 45,000 units
- Unexercised warrants at end of last month: 138,700 units (13,870,000 shares)
- Unexercised warrants currently: 93,700 units (9,370,000 shares)
- Total number of issued warrants: 240,000 units
AI要約
Section Heading
This is a notice regarding the large exercise of warrants issued through a third-party allotment. Of the 19th warrant with an exercise price adjustment clause issued on June 12, 2026, 45,000 units (equivalent to 18.8% of the total issued) were exercised from September 1 to September 10, and the issued shares amount to 4,500,000. Unexercised rights are currently 93,700 units (9,370,000 shares), continuing to be consumed compared with the beginning of the month. The total number of issued warrants involved is 240,000 units.
Section 2 Heading
It is necessary to examine the background of this large exercise, its impact on capital policy, and future dilution risks. Details on the trends of unexercised portions, movement of transferred treasury stock, changes in capital costs, and impact on business plans should be awaited in future disclosures. For details of this matter, please refer to the notice disclosed on May 27, 2026.
Modalis Therapeutics Corporation
Company overview · Stock price · Financial data · All IR
